Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$276M |
| 2 |
Procter & Gamble
PG
|
+$243M |
| 3 |
Analog Devices
ADI
|
+$188M |
| 4 |
Advanced Micro Devices
AMD
|
+$171M |
| 5 |
Home Depot
HD
|
+$162M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.95B |
| 2 |
Bristol-Myers Squibb
BMY
|
+$778M |
| 3 |
Walmart Inc
WMT
|
+$723M |
| 4 |
Zoom
ZM
|
+$642M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$573M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.3% |
| 2 | Technology | 17.17% |
| 3 | Consumer Staples | 12.21% |
| 4 | Communication Services | 9.94% |
| 5 | Consumer Discretionary | 9.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GMLP
2476
DELISTED
Golar LNG Partners LP
GMLP
| $1.08M | ﹤0.01% |
532,672
+70,968
| +15% | +$186K |
|
2477
Gyre Therapeutics
GYRE
$695M
| $1.08M | ﹤0.01% |
33,467
+22,426
| +203% | +$878K |
|
2478
Schwab U.S Small- Cap ETF
SCHA
$23.5B
| $1.08M | ﹤0.01% |
+63,200
| New | +$1.09M |
|
|
YI
2479
111 Inc
YI
$33.4M
| $1.08M | ﹤0.01% |
17,410
+3,325
| +24% | +$211K |
|
|
SRRA
2480
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $1.08M | ﹤0.01% |
101,074
+6,600
| +7% | +$78.6K |
|
2481
First US Bancshares
FUSB
$90.7M
| $1.07M | ﹤0.01% |
162,099
-1,400
| -0.9% | -$9.06K |
|
2482
XPEL
XPEL
$1.39B
| $1.07M | ﹤0.01% |
+41,100
| New | +$885K |
|
2483
Sysco
SYY
$40B
| $1.07M | ﹤0.01% |
17,200
-659,135
| -97% | -$38.4M |
|
2484
TAT Technologies
TATT
$525M
| $1.07M | ﹤0.01% |
217,100
+4,200
| +2% | +$16.7K |
|
|
VSA
2485
VisionSys AI
VSA
$10.3M
| $1.07M | ﹤0.01% |
243
-47
| -16% | -$199K |
|
|
LADR
2486
Ladder Capital
LADR
$1.28B
| $1.07M | ﹤0.01% |
150,041
-93,200
| -38% | -$701K |
|
2487
Everspin Technologies
MRAM
$415M
| $1.07M | ﹤0.01% |
188,206
+1,200
| +0.6% | +$7.64K |
|
2488
Metallus
MTUS
$895M
| $1.06M | ﹤0.01% |
298,269
+226,123
| +313% | +$868K |
|
2489
X4 Pharmaceuticals
XFOR
$421M
| $1.06M | ﹤0.01% |
5,201
+1,773
| +52% | +$425K |
|
2490
Astec Industries
ASTE
$971M
| $1.05M | ﹤0.01% |
+19,445
| New | +$973K |
|
2491
Weyco Group
WEYS
$437M
| $1.05M | ﹤0.01% |
65,128
-5,500
| -8% | -$100K |
|
|
JOBS
2492
DELISTED
51job Inc
JOBS
| $1.05M | ﹤0.01% |
13,494
-73,306
| -84% | -$5.09M |
|
2493
State Street Utilities Select Sector SPDR ETF
XLU
$22.9B
| $1.05M | ﹤0.01% |
35,400
-244,200
| -87% | -$7.25M |
|
2494
Fuel Tech
FTEK
$45.3M
| $1.05M | ﹤0.01% |
1,248,088
+41,450
| +3% | +$35.2K |
|
|
FWDI
2495
Forward Industries Inc
FWDI
$305M
| $1.05M | ﹤0.01% |
75,465
+2,594
| +4% | +$37K |
|
|
BLCM
2496
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $1.05M | ﹤0.01% |
159,571
-25,500
| -14% | -$173K |
|
2497
Summit Therapeutics
SMMT
$11.2B
| $1.04M | ﹤0.01% |
303,412
-57,700
| -16% | -$200K |
|
2498
Urban One Class D
UONEK
$24.1M
| $1.04M | ﹤0.01% |
89,081
-53,217
| -37% | -$740K |
|
|
SC
2499
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
| $1.04M | ﹤0.01% |
+57,200
| New | +$1.02M |
|
2500
State Street SPDR Nuveen ICE Municipal Bond ETF
TFI
$3.17B
| $1.04M | ﹤0.01% |
19,995
-59,205
| -75% | -$3.09M |
|
Similar funds
Jim Simons's Q3 2020 Portfolio in Review
As of Q3 2020, Jim Simons held 3,879 positions worth $100B, down 14% from $116B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Jim Simons withdrew a net $21.7B in Q3 2020, closing 544 positions and reducing 1,671 holdings. Its most notable exit was Alibaba, an estimated $426M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 24% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Jim Simons opened a new position in Microsoft worth $277M.
- Jim Simons's largest Q3 2020 buy was Microsoft: 1,315,812 shares worth $277M.
- Jim Simons added most to Procter & Gamble in Q3 2020, an estimated $243M increase.
- Jim Simons's biggest Q3 2020 reduction was Tesla, cutting an estimated $1.95B.
- Jim Simons fully exited Alibaba in Q3 2020, selling an estimated $426M.
- Jim Simons's ten largest holdings make up 15% of its $100B portfolio in Q3 2020.
- Jim Simons opened 490 new positions and closed 544 in Q3 2020.
- Jim Simons's portfolio value fell 14% quarter-over-quarter to $100B.
Based on Renaissance Technologies's 13F filing for Q3 2020, filed 13 Nov 2020.